Commercial Valerian interactions with [3H]flunitrazepam and [3H]MK-801 binding to rat synaptic membranes

Phytotherapy Research

Volumn 20, Issue 9, 2006, Pages 794-798

  Ortiz, José G ^a   Rassi, Nicole ^a   Maldonado, Patricia M ^a   González Cabrera, Silvia ^a   Ramos, Igmeris ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

3H flunitrazepam; 3H MK 801; UV spectra; Valerian

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DIZOCILPINE; FLUNITRAZEPAM; HYPNOTIC AGENT; TRANQUILIZER; VALERIAN;

ANIMAL CELL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG FORMULATION; DRUG INHIBITION; NONHUMAN; SEDATION; SPECTROSCOPY; STANDARDIZATION; SYNAPTIC MEMBRANE; ULTRAVIOLET RADIATION; VALERIANA OFFICINALIS;

ANIMALS; DIZOCILPINE MALEATE; FLUNITRAZEPAM; PLANT EXTRACTS; PLANT ROOTS; RATS; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC MEMBRANES; TRITIUM; VALERIAN;

VALERIANA; VALERIANA OFFICINALIS;

EID: 33748784053     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1960     Document Type: Article

References (32)

1. Abourashed EA, Koetter U, Brattstrom A. 2004. In vitro binding experiments with a Valerian, hops and their fixed combination extract (Ze91019) to selected central nervous system receptors. Phytomedicine 11: 633-638.
2. Andreatini R, Leite JR. 1994. Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepan withdrawal. Eur J Pharmacol 260: 233-235.
3. Andreatini R, Sartori VA, Seabra ML, Leite JR. 2002. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother Res 16: 650-654.
4. Bradford MM. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Bos R, Woerdenbag HJ, van Putten FM, Hendriks H, Scheffer JJ. 1998. Seasonal variation of the essential oil, valerenic acid and derivatives, and valopotriates in Valeriana officinalis roots and rhizomes, and the selection of plants suitable for phytomedicines. Planta Med 64: 143-147.
6. A receptor in rat brain. Arzneimittelforsch Drug Res 45: 753-755.
7. Dietz BM, Mahady GB, Pauli GF, Farnsworth NR. 2005. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res 138: 191-197.
8. Dominguez RA, Bravo Valverde RL, Kaplowitz BR, Cott JM. 2000. Valerian as a hypnotic for Hispanic patients. Cultur Divers Ethnic Minor Psychol 6: 84-92.
9. Fernandez SP, Wasowski C, Paladini AC, Marder M. 2005. Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. Eur J Pharmacol 512: 189-198.
10. Francis AJP, Dempster RJW. 2002. Effect of valerian, Valeriana edulis, on sleep difficulties in children with intellectual deficits: randomized trial. Phytomedicine 9: 273-279.
11. Gao XQ, Bjork L. 2000. Valerenic acid derivative and valepotriates among individual varieties and species of Valeriana. Fitoterapia 71: 19-24.
12. A receptors. Biochem Pharmacol 69: 1101-1111.
13. Granicher F, Christen P, Kapetanidis I. 1995. Essential oils from normal and hairy roots of Valeriana officinalis var sambucifolia. Phytochemistry 40: 1421-1424.
14. Hendriks H, Bos R, Allersma DP, Malingre THM, Koster ASJ. 1981. Pharmacological screening of valerenal and some other components of essential oil of Valeriana officinalis. Planta Med 42: 62-68.
15. Hendriks H, Bos R, Woerdenbag HJ, Koster AS. 1985. Central nervous depressant activity of valerenic acid in the mouse. Planta Med 1: 28-31.
16. Herrera Arellano A, Luna Villegas G, Ma L et al. 2001. Polysomnographic evaluation of the hypnotic effect of Valeriana edulis standardized extract in patients suffering from insomnia. Planta Med 67: 695-699.
17. Hindmarch DA. 2004. A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults. Phytother Res 18: 831-836.
18. Houghton PJ. 1999. The scientific basis for the reputed activity of Valerian. J Pharm Pharmacol 51: 505-512.
19. Leathwood PD, Chauffard F, Heck E, Munoz-Box R. 1982. Aqueous extract of Valerian root (Valeriane officinalis L) improves sleep quality in men. Pharmacol Biochem Behav 17: 65-71.
20. Lefebvre T, Foster BC, Drouin CE, Krantis A, Livesey JF, Jordan SA. 2004. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J Pharm Pharm Sci 7: 265-273.
21. Letchamo W, Ward W, Heard B, Heard D. 2004. Essential oil of Valeriana officinalis L. cultivars and their antimicrobial activity as influenced by harvesting time under commercial organic cultivation. J Agric Food Chem 52: 3915-3919.
22. Leuschner J, Muller J, Rudmann M. 1993. Characterization of the central nervous depressant activity of a commercially available valerian root extract. Arzneimittelforsch Drug Res 43: 638-641.
23. Malva JO, Santos S, Macedo T. 2004. Neuroprotective properties of Valeriana officinalis extracts. Neurotox Res 6: 131-140.
24. 3H]GABA release. Neurochem Res 24: 1373-1378.
25. Petkov V, Manolov P. 1975. To the pharmacology of iridoids. Agressologie 16: 25-30.
26. Poyares DR, Guilleminault C, Ohayon MM, Tufik S. 2002. Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? Prog Neuropsychopharmacol Biol Psychiatry 26: 539-545.
27. 3H]GABA in intraparenchymal fetal CNS tissue grafts. Exp Neurol 142: 66-79.
28. Shohet D, Wills RB, Stuart DL 2001. Valepotriates and valerenic acids in commercial preparations of valerian available in Australia. Pharmazie 56: 860-863.
29. Simmen U, Saladin C, Kaufmann P, Poddar M, Wallimann C, Schaffner W. 2005. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort. Planta Med 71: 592-598.
30. Ugalde M, Reza V, Gonzalez-Trujano ME, Avula B, Khan IA, Navarrete A. 2005. Isobolographic analysis of the sedative interaction between six central nervous system depressant drugs and Valeriana edulis hydroalcoholic extract in mice. J Pharm Pharmacol 57: 631-639.
31. A receptors, from Valeriana wallichii. Planta Med 68: 932-934.
32. Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie JT, Ang-Lee MK. 2004. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg 98: 353-358.